PT Kalbe Farma Tbk
PTKFF
Market Cap$3.42B
Close$
$0.15
93.6% upside
Current Fair Value
93.6% upsideUndervalued by 93.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.42 Billion |
|---|---|
| Enterprise Value | $-3,521,634,728,482.00 |
| Dividend Yield | $0.002196 (2.37623762376238%) |
| Earnings per Share | $70.22 |
| Beta | 0.06 |
| Outstanding Shares | 46,149,181,210 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 20.6 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -0.2 |
| Enterprise Value to EBIT | -1.36 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -0.29 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PT Kalbe Farma Tbk
CEO: Vidjongtius PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. T...